{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:23:56Z","timestamp":1792416236066,"version":"4.4.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"DOI":"10.1093\/jjco\/hyx010","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T08:27:19Z","timestamp":1485764839000},"page":"350-356","source":"Crossref","is-referenced-by-count":28,"title":["Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma\/non-small cell lung cancer)"],"prefix":"10.1093","volume":"47","author":[{"given":"Keisuke","family":"Tomii","sequence":"first","affiliation":[{"name":"Kobe City Medical Center General Hospital, Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Kanagawa Cancer Center, Yokohama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Yujin-Yamazaki Hospital, Hikone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Noma","sequence":"additional","affiliation":[{"name":"Tenri Hospital, Tenri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Kobashi","sequence":"additional","affiliation":[{"name":"Tenri Hospital, Tenri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Enatsu","sequence":"additional","affiliation":[{"name":"Eli Lilly Japan K.K., Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Okubo","sequence":"additional","affiliation":[{"name":"Eli Lilly Japan K.K., Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Eli Lilly Japan K.K., Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kudoh","sequence":"additional","affiliation":[{"name":"Japan Anti-Tuberculosis Association, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"key\n\t\t\t\t2018111510555219400_hyx010C1","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1158\/1078-0432.CCR-040010","article-title":"Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent","volume":"10","author":"Adjei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3816\/CLC.2009.s.006","article-title":"Updated clinical information on multitargeted antifolates in lung cancer","volume":"10","author":"Scagliotti","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.resinv.2013.09.001","article-title":"Consensus statement for the diagnosis and treatment of drug-induced lung injuries","volume":"51","author":"Kubo","year":"2013","journal-title":"Respir Invest"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jjco\/hyn024","article-title":"Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I\/II study in Japanese patients","volume":"38","author":"Nakagawa","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C5","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1158\/1078-0432.CCR-07-5143","article-title":"Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer","volume":"14","author":"Ohe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.lungcan.2011.08.002","article-title":"Safety and effectiveness of pemetrexed in patients with malignant pleural mesothelioma based on all-case drug-registry study","volume":"75","author":"Kuribayashi","year":"2012","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C7","first-page":"475","article-title":"Safety and effectiveness of pemetrexed in patients with non-small cell lung cancer in Japan \u2013 analysis of post-marketing surveillance","volume":"41","author":"Okubo","year":"2014","journal-title":"Jpn J Cancer Chemother"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C8"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C10","first-page":"405","article-title":"High prevalence of drug-induced pneumonia in Japan","volume":"50","author":"Azuma","year":"2007","journal-title":"JMAJ"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pds.2123","article-title":"Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan","volume":"20","author":"Nojiri","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/JTO.0b013e3182598abb","article-title":"Postmarketing Surveillance Study of Erlotinib in Japanese patients with non\u2013small-cell lung cancer (NSCLC) an interim analysis of 3488 patients (POLARSTAR)","volume":"7","author":"Nakagawa","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C13","first-page":"243","article-title":"Drug-induced pneumonitis: the role of methotrexate","volume":"18","author":"Zisman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key\n\t\t\t\t2018111510555219400_hyx010C14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1148\/radiographics.20.5.g00se081245","article-title":"Pulmonary drug toxicity: radiologic and pathologic manifestations","volume":"20","author":"Rossi","year":"2000","journal-title":"RadioGraphics"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/47\/4\/350\/26577101\/hyx010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:04:32Z","timestamp":1568761472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/47\/4\/350\/2966095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,2]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx010","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2017,2,2]]}}}